Spray Dry Technology for Pharmaceutical Development
With the acquisition of Pharmatek Laboratories, Catalent now offers spray drying as part of its bioavailability toolkit, complementing its comprehensive suite of development and formulation solutions.
From early phase development through to clinical manufacturing scale, spray drying can assist in overcoming formulation and development challenges.
With the acquisition of Pharmatek Laboratories, Catalent now offers spray drying as part of its bioavailability toolkit, complementing its comprehensive suite of development and formulation solutions. Additionally, the expansion of development and clinical manufacturing capabilities strengthens Catalent’s ability to partner with customers earlier in pre-clinical development.
Pharmatek’s San Diego facility expands Catalent’s global network of clinical and commercial manufacturing supply facilities, which integrates drug development and delivery for both oral and injectable dose forms. The site has the capacity to provide rapid development from prototype to optimal final dose form, with integrated characterization, analytical, pre-formulation, formulation, process development, and cGMP manufacturing. The facility has over 18,000 square feet of laboratory, manufacturing and support space dedicated to development and manufacturing of highly-potent compounds.
Spray drying technology will now be incorporated into OptiForm® Solution Suite, Catalent’s award-winning screening platform, to assess optimal formulation pathways for the oral delivery potential of both small and large molecule drugs.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
